I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 7 studies | 18% ± 4% | |
| glutamatergic neuron | 7 studies | 38% ± 24% | |
| macrophage | 7 studies | 25% ± 10% | |
| epithelial cell | 6 studies | 27% ± 12% | |
| endothelial cell | 5 studies | 25% ± 3% | |
| GABAergic neuron | 5 studies | 40% ± 20% | |
| microglial cell | 5 studies | 21% ± 6% | |
| monocyte | 4 studies | 18% ± 2% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 19% ± 4% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 25% ± 6% | |
| astrocyte | 4 studies | 28% ± 9% | |
| smooth muscle cell | 4 studies | 19% ± 4% | |
| interneuron | 4 studies | 38% ± 22% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 19% ± 4% | |
| myeloid cell | 3 studies | 19% ± 3% | |
| ciliated cell | 3 studies | 29% ± 8% | |
| oligodendrocyte precursor cell | 3 studies | 28% ± 7% | |
| dendritic cell | 3 studies | 27% ± 9% | |
| oligodendrocyte | 3 studies | 28% ± 5% |
